501 related articles for article (PubMed ID: 19544804)
1. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for
Assam I; Vijande J; Ballester F; Pérez-Calatayud J; Poppe B; Siebert FA
Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
6. Impact of interseed attenuation and tissue composition for permanent prostate implants.
Carrier JF; Beaulieu L; Therriault-Proulx F; Roy R
Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563
[TBL] [Abstract][Full Text] [Related]
7. Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant.
Afsharpour H; Pignol JP; Keller B; Carrier JF; Reniers B; Verhaegen F; Beaulieu L
Phys Med Biol; 2010 Aug; 55(16):4547-61. PubMed ID: 20668347
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
9. Sci-Sat AM(2): Brachy-05: Dosimetry effects of the TG-43 approximations for two iodine seeds in LDR brachytherapy.
Furstoss C; Bertrand MJ; Poon E; Reniers B; Pignol JP; Carrier JF; Beaulieu L; Verhaegen F
Med Phys; 2008 Jul; 35(7Part3):3416-3417. PubMed ID: 28512902
[TBL] [Abstract][Full Text] [Related]
10. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract][Full Text] [Related]
11. A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.
Afsharpour H; D'Amours M; Coté B; Carrier JF; Verhaegen F; Beaulieu L
Med Phys; 2008 Aug; 35(8):3671-81. PubMed ID: 18777927
[TBL] [Abstract][Full Text] [Related]
12. Comparison of TG-43 and TG-186 in breast irradiation using a low energy electronic brachytherapy source.
White SA; Landry G; Fonseca GP; Holt R; Rusch T; Beaulieu L; Verhaegen F; Reniers B
Med Phys; 2014 Jun; 41(6):061701. PubMed ID: 24877796
[TBL] [Abstract][Full Text] [Related]
13. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
Chiu-Tsao ST; Medich D; Munro J
Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
[TBL] [Abstract][Full Text] [Related]
14. The difference of scoring dose to water or tissues in Monte Carlo dose calculations for low energy brachytherapy photon sources.
Landry G; Reniers B; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2011 Mar; 38(3):1526-33. PubMed ID: 21520864
[TBL] [Abstract][Full Text] [Related]
15. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations.
Haidari AM; Miksys N; Soubiran P; Cygler JE; Holmes O; Perry G; Thomson RM
Brachytherapy; 2019; 18(6):875-882. PubMed ID: 31400953
[TBL] [Abstract][Full Text] [Related]
17. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
18. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
19. Tissue modeling schemes in low energy breast brachytherapy.
Afsharpour H; Landry G; Reniers B; Pignol JP; Beaulieu L; Verhaegen F
Phys Med Biol; 2011 Nov; 56(22):7045-60. PubMed ID: 22016111
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific Monte Carlo dose calculations for (103)Pd breast brachytherapy.
Miksys N; Cygler JE; Caudrelier JM; Thomson RM
Phys Med Biol; 2016 Apr; 61(7):2705-29. PubMed ID: 26976478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]